STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
25.38
+0.54 (2.15%)
Apr 24, 2026, 11:48 AM EDT - Market open
STAAR Surgical Company Stock Forecast
Stock Price Forecast
The 8 analysts that cover STAAR Surgical Company stock have a consensus rating of "Buy" and an average price target of $22.81, which forecasts a -10.11% decrease in the stock price over the next year. The lowest target is $16 and the highest is $28.
Price Target: $22.81 (-10.11%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for STAAR Surgical Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 8 | 10 | 10 | 11 | 9 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 10 | 11 | 12 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Hold Maintains $21 → $26 | Hold | Maintains | $21 → $26 | +2.46% | Apr 9, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold → Strong Buy Upgrades $22 → $27 | Hold → Strong Buy | Upgrades | $22 → $27 | +6.40% | Apr 9, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $31 → $16 | Hold | Maintains | $31 → $16 | -36.95% | Mar 5, 2026 |
| Stifel | Stifel | Hold Maintains $19 → $18 | Hold | Maintains | $19 → $18 | -29.06% | Mar 4, 2026 |
| Stifel | Stifel | Hold Maintains $28 → $19 | Hold | Maintains | $28 → $19 | -25.12% | Feb 9, 2026 |
Financial Forecast
Revenue This Year
313.23M
from 239.44M
Increased by 30.82%
Revenue Next Year
339.57M
from 313.23M
Increased by 8.41%
EPS This Year
-0.07
from -1.62
EPS Next Year
0.23
from -0.07
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 336.2M | 374.3M | ||||
| Avg | 313.2M | 339.6M | ||||
| Low | 272.9M | 290.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 40.4% | 19.5% | ||||
| Avg | 30.8% | 8.4% | ||||
| Low | 14.0% | -7.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 0.46 | 0.98 | ||
| Avg | -0.07 | 0.23 | ||
| Low | -0.91 | -0.84 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.